Cargando…

Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian’s with chronic myeloid leukemia

OBJECTIVES: Imatinib has shown to be highly efficacious in the treatment of chronic myeloid leukemia (CML) but continuous dosing and patient adherence is essential treatment success. The study aimed to assess prevalence and reasons for non-adherence to Imatinib in newly diagnosed patients with CML i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulu Fentie, Atalay, Tadesse, Fishatsion, Engidawork, Ephrem, Gebremedhin, Am
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405163/ https://www.ncbi.nlm.nih.gov/pubmed/30845227 http://dx.doi.org/10.1371/journal.pone.0213557

Ejemplares similares

Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia
por: Tadesse, Fisihatsion, et al.
Publicado: (2021)

Multicentre point-prevalence survey of antibiotic use and healthcare-associated infections in Ethiopian hospitals
por: Fentie, Atalay Mulu, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy among Ethiopian healthcare workers
por: Mohammed, Rihanna, et al.
Publicado: (2021)

Impact of Delay Prior to Treatment in Ethiopian Children with Acute Lymphoblastic Leukemia
por: Hailu, Abel, et al.
Publicado: (2023)

Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital
por: Mohammed, Husnia Bedewi, et al.
Publicado: (2019)

Reliability and validity of the Amharic version of immune thrombocytopenia life quality index tool for assessment of the health-related quality of life in Ethiopian patients of immune thrombocytopenia: Cross-sectional study
por: Beyene, Dessale Abate, et al.
Publicado: (2023)

Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia
por: Fentie, Atalay Mulu, et al.
Publicado: (2020)

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
por: Cortes, Jorge E., et al.
Publicado: (2018)

Current status, challenges and the way forward for clinical pharmacy service in Ethiopian public hospitals
por: Bilal, Arebu Issa, et al.
Publicado: (2017)

Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
por: Ibrahim, Ali, et al.
Publicado: (2022)

Insulin injection practice and health related quality of life among individuals with diabetes at Tikur Anbessa Specialized Hospital, Ethiopia: a cross-sectional study
por: Negash, Zenebe, et al.
Publicado: (2023)

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2014)

Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
por: Brümmendorf, Tim H., et al.
Publicado: (2022)

Incidence and Determinants of Chemotherapy Associated Thromboembolic Events among Ethiopian Patients Treated for Solid Malignancy: A Retrospective Cross-Sectional Study
por: Yabeyu, Abdella Birhan, et al.
Publicado: (2022)

Genotoxicity study of Ethiopian medicinal plant extracts on HepG2 cells
por: Kahaliw, Wubayehu, et al.
Publicado: (2018)

Assessment of adequacy and appropriateness of pain management practice among trauma patients at the Ethiopian Aabet Hospital: A prospective observational study
por: Ayano, Wondwossen Alemu, et al.
Publicado: (2023)

The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis
por: Mealing, Stuart, et al.
Publicado: (2013)

Tuberculosis treatment outcome among patients treated in public primary healthcare facility, Addis Ababa, Ethiopia: a retrospective study
por: Fentie, Atalay Mulu, et al.
Publicado: (2020)

Incidence of depression in people with newly diagnosed tuberculosis in Ethiopia: a cohort study
por: Ambaw, Fentie, et al.
Publicado: (2020)

Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
por: Chuah, Charles T., et al.
Publicado: (2014)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
por: Brümmendorf, Tim H, et al.
Publicado: (2015)

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia
por: Ambaw, Fentie, et al.
Publicado: (2017)

Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
por: Kantarjian, Hagop M., et al.
Publicado: (2021)

Evaluation of the antimycobacterial activity of crude extracts and solvent fractions of selected Ethiopian medicinal plants
por: Kahaliw, Wubayehu, et al.
Publicado: (2017)

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients
por: Qin, Ya-Zhen, et al.
Publicado: (2016)

Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study
por: Kefale, Belayneh, et al.
Publicado: (2018)

Management Practice, and Adherence and Its Contributing Factors among Patients with Chronic Kidney Disease at Tikur Anbessa Specialized Hospital: A Hospital Based Cross-Sectional Study
por: Kefale, Belayneh, et al.
Publicado: (2018)

Adherence to iron and folic acid supplementation and prevalence of anemia among pregnant women attending antenatal care clinic at Tikur Anbessa Specialized Hospital, Ethiopia
por: Nasir, Beshir Bedru, et al.
Publicado: (2020)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study
por: Alemu, Jemal, et al.
Publicado: (2023)

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
por: Gebremariam, Girma Tekle, et al.
Publicado: (2022)

Factors Influencing Adherence to Imatinib in Indian Chronic Myeloid Leukemia Patients: A Cross-Sectional Study
por: Kapoor, Jyotsna, et al.
Publicado: (2015)

The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire
por: Koffi, K. G., et al.
Publicado: (2010)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Ramchandren, Radhakrishnan, et al.
Publicado: (2009)

Monitoring imatinib plasma concentrations in chronic myeloid leukemia
por: Martins, Darlize Hübner, et al.
Publicado: (2011)

Targeted treatment of chronic myeloid leukemia: role of imatinib
por: Tamascar, Ila, et al.
Publicado: (2009)

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?
por: Trela, Ewelina, et al.
Publicado: (2014)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
por: Chandra, Abhilash, et al.
Publicado: (2020)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nkrgcuu0db9tv1q4jtne6chp1t